Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin add-on therapy for neuropathic pain after thoracic surgery
jRCTs071200053Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mirogabalin in Neuralgia (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Primary endpoint: change in resting pain intensity (VAS) at 8 weeks. Started Dec 2020; status: completed.
02
Drugs
mirogabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on jRCTs071200053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200053.